Algeria vs Iceland: Cause of death, by non-communicable diseases, ages 5-14
Algeria
41.6%
in 2021
Iceland
41.7%
in 2021
Algeria rank
76th
Iceland rank
75th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Algeria
- Iceland
How they compare
Iceland currently reports 41.7% against 41.6% in Algeria, a difference of 0.1%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Iceland ahead.
Algeria ranks 76th and Iceland ranks 75th of 185 countries.
Across the 3 decades both report, Algeria averaged higher in 1 and Iceland in 2.
Head to head by decade
| Decade | Algeria | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 39.8% | 52.9% | 13.2% | Iceland |
| 2010s | 44.4% | 66.1% | 21.8% | Iceland |
| 2020s | 43.9% | 41.1% | 2.8% | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Algeria or Iceland?
- Iceland, at 41.7% against 41.6% in Algeria as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Algeria and Iceland?
- 0.1%, with Iceland ahead.
- How many years of comparable data are there for Algeria and Iceland?
- 6 years are reported by both, from 2000 to 2021.
- How do Algeria and Iceland rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Algeria ranks 76th and Iceland ranks 75th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.